Optimizing Biomedical Health Efficiency: Unlocking the Full Potential of Life Science Innovation Through System Design

Eric NormanArticles

Our new analysis is now available open access in Therapeutic Innovation & Regulatory Science: Optimizing Biomedical Health Efficiency: Unlocking the Full Potential of Life Science Innovation Through System DesignAuthors Gigi … Read More

BioCentury OpEd: Biomedical Innovation Requires Health System Innovation

Eric NormanArticles, Precision Access Systems

New guest commentary in BioCentury by Gigi Hirsch & Jane Barlow seeds a series of discussions now underway to shape priorities for the “Next Big Thing” in the Center for … Read More

BioCentury OpEd: Biomedical Innovation Requires Health System Innovation

Eric NormanArticles

New guest commentary in BioCentury by Gigi Hirsch & Jane Barlow seeds a series of discussions now underway to shape priorities for the “Next Big Thing” in the Center for … Read More

How can self-insured employers prepare for the portfolio impact of highcost gene therapies coming to market?

Eric NormanFoCUS, Research Briefs

Self-insured employers (SIEs) currently rely on traditional stop-loss insurance to protect against unexpected high-cost claims, including those for cell and gene therapies. Given that current approvals are in rare diseases, … Read More

Precision for Whom? Partnering with patients to ensure that Precision Medicine targets what matters

Eric NormanLEAPS, Research Briefs

Despite decades of growth and adaptation in patient engagement, knowing or being able to find guidance for whichmodel or approach will be most impactful in which healthcare or research context … Read More

The resource navigation challenges for patients and caregivers

Eric NormanFoCUS, Research Briefs

Share the researchWhile the problem of finding system-wide, implementable precision financing models for curative and durable therapies involves all stakeholders, patients and caregivers are directly affected by many different elements … Read More

Downstream Innovation Part II

Eric NormanLEAPS, Research Briefs

December 2019 marked the transition from the LEAPS two-year design and feasibility assessment phase to the rollout of the rheumatoid arthritis in Massachusetts (RA MA) Pilot. Some important themes surrounding … Read More